Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company develops a drug “endoxifen” and a new way to deliver therapies, such as “CAR-T” cells, through its microcatheters directly to the site of the breast cancer.